In last trading session, NKGen Biotech Inc (NASDAQ:NKGN) saw 0.36 million shares changing hands with its beta currently measuring 0.69. Company’s recent per share price level of $0.39 trading at $0.02 or 5.88% at ring of the bell on the day assigns it a market valuation of $14.00M. That closing price of NKGN’s stock is at a discount of -941.03% from its 52-week high price of $4.06 and is indicating a premium of 48.72% from its 52-week low price of $0.20. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.33 million shares which gives us an average trading volume of 1.29 million if we extend that period to 3-months.

NKGen Biotech Inc (NASDAQ:NKGN) trade information

Upright in the green during last session for gaining 5.88%, in the last five days NKGN remained trading in the green while hitting it’s week-highest on Wednesday, 11/27/24 when the stock touched $0.39 price level, adding 11.36% to its value on the day. NKGen Biotech Inc’s shares saw a change of -85.67% in year-to-date performance and have moved 16.77% in past 5-day. NKGen Biotech Inc (NASDAQ:NKGN) showed a performance of 37.32% in past 30-days. Number of shares sold short was 0.69 million shares which calculate 0.28 days to cover the short interests.

NKGen Biotech Inc (NASDAQ:NKGN)’s Major holders

Insiders are in possession of 42.32% of company’s total shares while institution are holding 12.19 percent of that, with stock having share float percentage of 21.14%. Investors also watch the number of corporate investors in a company very closely, which is 12.19% institutions for NKGen Biotech Inc that are currently holding shares of the company.

On the other hand, Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 68.97 shares of worth $27586.0 or 0.20% of the total outstanding shares. The later fund manager was in possession of 53.8 shares on Jun 30, 2024 , making its stake of worth around $21521.0 in the company or a holder of 0.15% of company’s stock.